News Harm Reduction Therapeutics In The News The latest stories and news about Harm Reduction Therapeutics, OTC RiVive™, and naloxone Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive™ Life-Saving Over-the-Counter Naloxone Nasal Spray Sep 3, 2024 Compassionate Overdose Response Summit Highlights and Key Takeaways Aug 27, 2024 A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and Veterans Aug 14, 2024 Statement Regarding High Dose Naloxone and Long Acting Nalmefene Opioid Overdose Reversal Formulations Jul 29, 2024 Exploring Cost and the Emerging Landscape of Naloxone Competition Jul 22, 2024 Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™ Mar 1, 2024 Higher naloxone doses have no impact on overdose survival, study shows Feb 8, 2024 Bystander Naloxone Administration: Amounts and Dosages versus EMS Naloxone Administration Feb 3, 2024 First Shipment of RiVive™ Brings Life-Saving Over-The-Counter Naloxone Nasal Spray One Step Closer to Those Who Need It Most Dec 18, 2023 Load More
